VNDA — Vanda Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $244.87m
- $82.02m
- $216.11m
NASDAQ TRADE HALT HALT NEWS PENDING AT 05:43 PM
U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia
U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow
Vanda Pharmaceuticals rises after BLA for rare skin disease treatment
Brief: Vanda Announces Submission Of Biologics License Application To The FDA For Imsidolimab For The Treatment Of Generalized Pustular Psoriasis
Vanda Pharmaceuticals gains after FDA lifts partial clinical hold on motion sickness treatment
U.S. STOCKS ON THE MOVE-ASP Isotopes, gold miners, energy companies
U.S. STOCKS ON THE MOVE-Silver miners, Jefferies, Vanda
Vanda falls as US FDA extends review of motion sickness drug
Brief: Vanda Pharmaceuticals Provides Regulatory Update On Tradipitant For Motion Sickness
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Energizer Holdings, Target
U.S. STOCKS ON THE MOVE-Ardent Health, Intuit, Galmed Pharma
Vanda set for best day in over five months as nausea drug shows promise for GLP-1 side effects
U.S. STOCKS ON THE MOVE-Cloudflare, Legence, Lumentum
U.S. STOCKS ON THE MOVE-Vanda, Archer Aviation, Axalta
Vanda rises as nausea drug shows promise for GLP-1 side effects
Brief: Vanda Pharmaceuticals Reports Positive Results For Tradipitant In Preventing Glp-1 Induced Nausea And Vomiting
Vanda Pharma Q3 sales rises, driven by Fanapt growth
Brief: Vanda Pharmaceuticals Q3 EPS USD -0.38